Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Testing glucose tolerance right after childbirth

Official title: Immediate Postpartum Glucose Tolerance Testing Among Gestational Diabetics: A Comparison to the Gold Standard

Run by MemorialCare Health System · NCT04199676 · Data updated 2026-11-12

This study is trying to see if testing blood sugar right after childbirth can help women with gestational diabetes get better care and catch any ongoing issues sooner than the usual test done six weeks later.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment300 (estimated)
SponsorMemorialCare Health System
Academic / other
Locations1 site (Long Beach, California)
StatusRecruiting
StartedSeptember 1, 2020
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 3, 2025
Trial IDNCT04199676 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women who are pregnant or have recently given birth (postpartum day 0 or 1) and have been diagnosed with gestational diabetes.

Probably not a fit

Patients who are medically excluded from completing glucose tolerance testing or those who have received steroid treatment within 10 days prior to enrollment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the accuracy of a two-hour glucose tolerance test conducted during postpartum hospitalization with the standard glucose tolerance test performed six weeks after delivery. It aims to determine if testing immediately postpartum can improve compliance rates among women diagnosed with gestational diabetes. The study will capture data on women with gestational diabetes to assess the effectiveness of immediate testing in identifying those with persistent glucose intolerance. By addressing low compliance rates, the study seeks to enhance early diagnosis and treatment opportunities for women at risk of developing type 2 diabetes.

Why it matters

Potential benefit: If successful, this approach could lead to earlier identification and management of glucose intolerance in postpartum women, reducing the risk of developing type 2 diabetes.

How similar studies have gone: While the approach of immediate postpartum glucose testing is innovative, similar studies have not been widely reported, indicating this may be a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant or recently postpartum (postpartum day 0 or 1)
* ≥ 18 years of age
* Gestational age ≥34 weeks
* A1 or A2 gestational diabetes

Exclusion Criteria:

* Medical exclusion from completing glucose tolerance testing
* Steroid administration within 10 days prior to enrollment
* Chronic steroid use

Where it's running

  • Long Beach Memorial Medical Center/Miller Children's and Women's Hospital
    Long Beach, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.